Division of Charles River Laboratories International Inc.
Latest From Oncotest GmbH
Sanofi pushed ahead to advance its leadership in diabetes in a partnership with Hanmi; Pfizer bought Allergan in biopharma's biggest M&A to date, at $160bn. Boston Pharma's $600m financing contributed greatly to the early-stage venture category's 50% share of total financing.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2015.
Drug Discovery Tools
- Molecular Diversity
- Drug Discovery Tools
- Contract Research, Toxicology Testing-CRO
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- Charles River Laboratories International Inc.
- Senior Management
Heinz-Herbert Fiebig, MD, PhD, Co-CEO
Ingmar Peitz, PhD, Head, Strategic Bus. Dev. & CFO
- Contact Info
Phone: 761 51559 0
Am Flughafen 12-14
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.